Dexamethasone oxuspheres - Oxular
Alternative Names: DEXAspheres®; OXU-001Latest Information Update: 27 Jul 2023
At a glance
- Originator Oxular
- Class Anti-inflammatories; Antiallergics; Antiemetics; Antihyperglycaemics; Antineoplastics; Antirheumatics; Eye disorder therapies; Fluorinated steroids; Glucocorticoids; Ketones; Non-opioid analgesics; Phosphates; Pregnadienetriols; Small molecules; Sodium compounds; Vestibular disorder therapies
- Mechanism of Action Glucocorticoid receptor agonists; Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Phase II Diabetic macular oedema
- Preclinical Retinal vein occlusion; Uveitis
Most Recent Events
- 14 Jul 2023 Phase-II clinical trials in Diabetic macular oedema in Puerto Rico (Ophthalmic) (NCT05697809)
- 14 Jul 2023 Phase-II clinical trials in Diabetic macular oedema in USA (Ophthalmic) (NCT05697809)
- 23 Mar 2023 Chemical structure information added